ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000950.1|Napsamycin_2 # 1184 # 1834 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGC;rbs_spacer=10bp;gc_cont=0.685	BGC0000950.1|Napsamycin_2 	1184	1834	-	Loose	275	40.4318	AAC(6')-34	22.94	3003989	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGCGTCTCCGGCACCGGACCACACTGACAGGAGTCAGGGTGCCGCAGCCTCACTTCGCGGGCCAAGTGGAAAAGCCGAACTTCGCCTCCCTCCGGAATCCGTGCGCTAGGTTGTCCGTCATGAGTGAACTCGGATCAGGCACCTGGCCCCCCGCCCCGATAAAGACCGAACGGCTCGTGCTCCGCGAGTCGGAGTCCCGGGACCGCGCGGCGTTCGTCGAGTTGTTCGCCTCGCCGGAGGTGGGCACCTTCATCGGTGGCGCGCGACCACGAGACGACCTCGAGCGTGCGGTGCCCGAGACGCCCGGGCGGCGTCCCGGCTTCTTCGTGATCGAACGCGACGGAGCGATGATCGGAATGGTCACCCTCGACCGACGCGAGGAGCGACCGGGGCGCGCCCGTCCCGAAGCCGGCCTGACCGAGCTCGGCTATCTGTTCTTGCCGCAGGCGTGGGGACACGGATACGCCGCCGAGGCGTGCACGGCGATCCTCGACTGGTTCGCCGGCACTCTCCCCGGCGCACCGGTCGTGCTCACCACTCAGTCCGCCAACGACCGCGCGATGCGCCTCGCCGAGAAGCTGGGGTTCACCGAGGTGGAGCGGTTCGAGGAATTCGGCGCCGAGCAGTGGTTCGGCGAGTGGACCCCCTGA	MRLRHRTTLTGVRVPQPHFAGQVEKPNFASLRNPCARLSVMSELGSGTWPPAPIKTERLVLRESESRDRAAFVELFASPEVGTFIGGARPRDDLERAVPETPGRRPGFFVIERDGAMIGMVTLDRREERPGRARPEAGLTELGYLFLPQAWGHGYAAEACTAILDWFAGTLPGAPVVLTTQSANDRAMRLAEKLGFTEVERFEEFGAEQWFGEWTP	MRIGDLIREDGGIAMLVYEAGPITVRELEEKDEISLASWLSNPDVLQYYEGRDNPHDVERVREHFYVDDDETRCIIKYEGKPIGYIQFYLLDEETLGEYGYNESDADCRTFATDQFIGEPDYWNRGIGTKLMTSMVEYLVFQRQADRIVMDPQAWNERAIACYEKCGFRKVRLLEKHEQHEGELRDCWIMEYRAERK	109.64	gnl|BL_ORD_ID|2233|hsp_num:0	2525			66	549	kanamycin A
BGC0000950.1|Napsamycin_3 # 1838 # 2656 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.656	BGC0000950.1|Napsamycin_3 	1838	2656	+	Loose	50	28.4906	vanW gene in vanI cluster	27.27	3003724	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanW; glycopeptide resistance gene cluster	ATGGCATGCCGACAGGCGCCCGTACATTTCCATACCTTCTGGGACGGATCGATGAGGCCTACGCTGCTGAGAATCGCGACCTGGAACATGGGCGGCGGGATCCTCGGGGAATCCCACCAACGCGACGGGATTCCCTCGCTCGATTACTACGCCTCAGTCCTGGCGGATCACCGCCCTGACGTTCTGTGTCTGCAAGAGGCGCATGATTATGACGGCCGCCGGGAAAGCCAGTCGGAATATCTGGCGAGGCGCCTCGAATATGCGCACTCACTGTCTTTCCCTCTCAGCGTTTCACACATGGCGAAGGATGCTTCCCTCGCCCTGGGTATCCTCTCGCGGTTCCCGATCGCGAAAACCGTGTACAAACGTTTTCCCCGGCCACAGCTGGTCGGTACCGGCCCGCGGGGCGAGCGCTGGACCCTTCACGACAAGGGCTACATGGTCGGGTCGATCGCCCTCGGCGACCGGATGCTCGGGTTCGTCAACGGGCACTGTTTCCCTCTGAGGCGCTTCGGCGCGAGCGCCACCGAGCCGGCGTTCGCGCCGGTGTGGGCCATGCTCACGGCAGACCTGCTGGCCGTCGGCGGCACGGGGACAGCCTTCGCCGCCCTCGACGCGAATCACGGGCGGATAGGCGAGGTGCTCGGGGACGTCCTGGGCCCCGGGCACTACCGGAGCGCCTTCGAGGCCACCCCCACGACCCCCGGGGGCGGACAGAAGGACCACATTCTCTACGGGCGGGCACTGCGGCTGCTCAGCACGACGGTGGCCGCGACCGAGTCCGACCATTCTTATTGCCAGGTGAGTGTGCTGGTGTAG	MACRQAPVHFHTFWDGSMRPTLLRIATWNMGGGILGESHQRDGIPSLDYYASVLADHRPDVLCLQEAHDYDGRRESQSEYLARRLEYAHSLSFPLSVSHMAKDASLALGILSRFPIAKTVYKRFPRPQLVGTGPRGERWTLHDKGYMVGSIALGDRMLGFVNGHCFPLRRFGASATEPAFAPVWAMLTADLLAVGGTGTAFAALDANHGRIGEVLGDVLGPGHYRSAFEATPTTPGGGQKDHILYGRALRLLSTTVAATESDHSYCQVSVLV	MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK	72.92	gnl|BL_ORD_ID|4746|hsp_num:0	2242			624	972	vancomycin; teicoplanin
BGC0000950.1|Napsamycin_4 # 2783 # 3067 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.635	BGC0000950.1|Napsamycin_4 	2783	3067	+	Loose	2000	23.0978	Bifidobacterium adolescentis rpoB mutants conferring resistance to rifampicin	32.0	3004480	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic target alteration; antibiotic target replacement	rifamycin-resistant beta-subunit of RNA polymerase (rpoB)	ATGAGTCTGCAGAACGCAAAGGCGCCGGAACGCGTCGCGGTCCTGACCCGGATCTGGCGAGAGGTTCTCGGAGATCCCGCCCTCGACGAGAATGCGGATCTCTTCGAGAAGAACGGATCGTCGTTGCAGGTCCTGCAGATCACCGGCAGGATCCACGACGCCCTCGGTATCGACGTGAAGCTGCGTCACGTATTCTCGTACGCCTCGCCGCGCAGCCTTTCCGATTTCCTCGACGCCGAGTTCGCGCAGGGGGATTCCGGCGCGGTGCACGGCGGCGAGAAGTGA	MSLQNAKAPERVAVLTRIWREVLGDPALDENADLFEKNGSSLQVLQITGRIHDALGIDVKLRHVFSYASPRSLSDFLDAEFAQGDSGAVHGGEK	MAEATTNTTTIIARADQHDIDLHKASDRVNFGSIREPIDVPYLLGVQTDSFDWLIGNERWQKRVQEDLENGTNTVPHTSGLDEVFQEISPIENFAQTMSLTFSDPYFEEPRHTVQECKEKDYTYSAPLYVNAEFENGDTGEIKSQTVFMGDFPLQTPHGTFIIGGTERVIVSQLVRSPGVYFDRSQDRTSDKEVFGAKIIPSRGAWLEFEIDKRDVLGVRVDRKRKQSAIVFLMAIGMTKDEIADAFKDYPLVMDALAKETVQTQDEALTDLYRKIRPADTPTPEAGKNLLDSFYFNTKRYDLARVGRYKINRKLGLEKDVNDRSLSREDIIATIKYLVTLHAGETKFPGKRDGQDVDLRVDVDDIDHFGNRRIRQVGELIQNQLRTGLSRMERVVRERMTTQDPEAITPQSLINIRPVNATIKEFFGTSQLSQFMDQNNPLAGVTNKRRLSALGPGGLSRDRASMEVRDVHPSHFGRMCPIESPEGPNIGLIGSLATFGRINPFGFIETPYRKVVNGHVTDEVEYMTADRDAEHVIAQANQELDENGNFVKKQALARVGEEEAVDVPVSSVDYMDVSPRQMVSVGASLIPFLEHDEGHRALMGTNMQRQAVPLIESERPLVGTGAEWRAAVDSGDVILAEKPGVVTYVSADIIRTMNDDGTTSSYKLAKFQRSNQTTCYNQVPLIHDGERVEAGTVLADGPATQKGEMALGKNLLIAFMPWNGYNYEDAVIISQRLVQDDTLSSIHIEEYEIDARETKLGAEEITRDLPNVGEDAVANLDERGIIRIGAEVEAGDILVGKVTPKGETELTPEERLLRAIFGEKSREVRDTSLRVPHGETGTVIAVKEITREDAEEDGDELPNGVNQMIRVYIAQHRKITQGDKLSGRHGNKGVISRILPEEDMPFLADGTPVDIMLNPLGVPSRMNLGQVLELHLGWIAHAGWDISLDPDAEAAWKKYVPQGAEKGAPGTPVATPVFDGVRPETIKGLLSCTLPDRDGNKLVGPDGKATLFDGRTGEPFPKPISVGYMYMLKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMEVWALEAYGAAYTLHEMMTTKSDDVDGRVRVYGAIVKGENLPPAGIPESFKVLLKEMQSLSLNVEVLNADGVAIDMKEEDDDPSTSSDDLGFNIGARPDAAAKEDQVAEEPEFQ	7.93	gnl|BL_ORD_ID|4719|hsp_num:0	2914			363	426	rifampin
BGC0000950.1|Napsamycin_6 # 4347 # 4571 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.733	BGC0000950.1|Napsamycin_6 	4347	4571	+	Loose	1900	22.3274	MuxB	39.39	3004074	protein homolog model	n/a	n/a	macrolide antibiotic; monobactam; tetracycline antibiotic; aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTCCGACGACGAGGCAGGCGAGTTCCGCATCGTGCGGAACGGCGAGGAGCAGTACTCGGTCTGGCCGGCCGGGCAGGATCTGCCCGCCGGCTGGTTCGAGGTGGGGCAGCGGGGCACGAGGGCTGACTGCCTGGCCCGTGTCGGCCGTTCCTGGACGGACATGCGGCCGGCGAGCCTGCGCCGCGGTCCGTCCGGCGACGAGGACGGGGCCACCCGAGGATGA	MSDDEAGEFRIVRNGEEQYSVWPAGQDLPAGWFEVGQRGTRADCLARVGRSWTDMRPASLRRGPSGDEDGATRG	MNPSRPFILRPVATTLLMVAILLSGLIAYRFLPISALPEVDYPTIQVVTLYPGASPEIMTSSITAPLENQLGQIPGLNEMSSSSSGGASVITLQFSLQSNLDVAEQEVQAAINAAQSLLPNDLPNQPVFSKVNPADAPILTLAVMSDGMPLPQIQDLVDTRLAQKISQISGVGLVSISGGQRPAVRVRANPTALAAAGLSLEDLRSTVTSNNLNGPKGSFDGPTRASTLDANDQLRSADAYRDLIIAYKNGSPLRIRDVASVEDDAENVRLAAWANNLPAVVLNIQRQPGANVIEVVDRIKALLPQLQSTLPGNLDVQVLTDRTTTIRASVKDVQFELALAVALVVMVTFLFLRNVYATLIPSFAVPLSLIGTFGVMYLSGFSINNLTLMALTIATGFVVDDAIVMVENIARYLEQGDSPLEAALKGSKQIGFTIISLTFSLIAVLIPLLFMGDVAGRLFREFAITLAVAILISGFVSLTLTPMLSAKLLRHIDEDQQGRFARAAGRVIDGLIAQYAKALRVVLRHQPLTLLVAIATLALTALLYLAMPKGFFPVQDTGVIQGVAEAPQSISFQAMSERQRALAEVVLKDPAVASLSSYIGVDGSNPTLNTGRLLINLKPHSERDVTASEVIQRLQPELDHLPGIKLYMQPVQDLTIEDRVARTQYQFTLQDADPDVLAEWVPKLVARLQELPQLADVASDWQDKGLQAYLNIDRDTASRLGVKLSDIDSVLYNAFGQRLISTIFTQATQYRVVLEVAPQFQLGPQALEQLYVPSSDGTQVRLSSLAKVEERHTLLAINHIAQFPSATLSFNLAKGYSLGEAVEAIRGVEASLELPLSMQGSFRGAALAFEASLSNTLLLILASVVTMYIVLGILYESFIHPVTILSTLPSAGVGALLALMLAGQEIGIVAIIGIILLIGIVKKNAIMMIDFALDAERNEGKPPHEAIYQACLLRFRPILMTTMAALLGALPLMLAGGAGAELRQPLGITMVGGLLLSQVLTLFTTPVIYLYFDRLARRWAAWRKQRGLDLNTEAGFDGDAGR	7.09	gnl|BL_ORD_ID|2364|hsp_num:0	2718			579	678	erythromycin; tetracycline; novobiocin; aztreonam; kitasamycin; rokitamycin
BGC0000950.1|Napsamycin_7 # 4568 # 5899 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=GGC;rbs_spacer=9bp;gc_cont=0.733	BGC0000950.1|Napsamycin_7 	4568	5899	+	Loose	1400	33.4982	Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid	32.46	3003392	protein variant model	F483L, L430V	n/a	isoniazid-like antibiotic	antibiotic target alteration	isoniazid resistant katG	ATGAACGCTTTCACCGGGGCCTTCTGGCGGAGCGGCGACCCCGGCTTCGCCGATGCCGCGACCGCACGCGTCTTCAACCGCCGGCTGCCCTCGCGGCGTCCGGCAGCGGTGCTGCGGGCCGCCGACGTCACCGACGTCGCGGAGGGGGTGAGGCTGGCAGCGGCGGAGGGCTGGCGGGTCGCCGTCCGTTCCGGCGGGCACAGTTGGGCCGCCTGGTCACTGCGCGAGGACACCCTGCTCATCGACCTCGCGCTGTTCACCGGGATGTCCTACGACCCCGCCGACGCGACCGTGACCGTGGGCCCGGCAGTACGCGGCGGCCTGGACCTGGACCCGTATCTCGCCGGGCACGGCCGGTTCTTTCCCGTGGGCCACTCCCCCAGCGTCGGCATGGGAGGCTTCCTGCTCCAGGGTGGTATCGGCTGGAACTGCCGCGGCTGGGGCTGGGCCGCCGAGTCCCTCGTGTCCATGGAGGTGGTGACCGCCGCCGGGGAGGTGGTGCGGTGCTCCGAGACGGAGAACGCCGATCTGTTCTGGGCGGCGCGCGGCTCGGGGCCCGGATTCTTCGGAGTGGTCACCGCCTTCCGGCTGCGGACCCGTCCCCGCTTCCGGGAGCTGACGCGGTCTGCGTACGTCTTCCCCTCCGAGCTCGCCGCGGAGGTCCTGAGCTGGTACCACGTGGCCCGCCACGACCTGCCGGCGTCGGTCGAGCTGGCCGCCGTCGGCTCCACGCCGCCCGGCTCCGACGCTCCGGTACTGACCGTCGACGCCGTGTCGTTCGACGGCGGCCCGGCCTCGCTGGCCGCACTCGATTCGTCTCCGGTGGTCGCCAGGGCCTCGGCACGCACGGTCGCCGAGCCGGTGGACTTCGCGGAGCTCCAGGCGGAGCAGCTGCGCGGCAATCCGGAGAACCACCGGTACGCCGCGGACAACGCCTTCCTCTCCGGTTCCGCGTCGGAGCTGGTTCCGGCGCTGGTGCCCGCCTTCACCGAGCTGCCCACGCCCAGGACGTTCACGGTCCTGGGCGACTTCACGCCGCTGGTCGCCCGCCGCCCCCCGGACATGGCGGTGTCGCTGCAGACCGACCTCTACTTCGCCGCGTACGCGATTGGCACGACCCCCGCCGACGATGTCCTGAGCCGGACGTGGCTCGACCGCACGATGAGCCGCCTGGCGCCTCACTCGGTCGGCTGCTACCTCGGGGACAGCGACCTCGCCGTCCGGGCGGACCGGATCATGTCGGACGCCGCCTGGTCGGCATTCCGGCGGATCCGTGCCGCCCGGGACCCCGAGGGCCGCTTCCCCGGCTACCTCGGTGACCCCGCGCAGTAG	MNAFTGAFWRSGDPGFADAATARVFNRRLPSRRPAAVLRAADVTDVAEGVRLAAAEGWRVAVRSGGHSWAAWSLREDTLLIDLALFTGMSYDPADATVTVGPAVRGGLDLDPYLAGHGRFFPVGHSPSVGMGGFLLQGGIGWNCRGWGWAAESLVSMEVVTAAGEVVRCSETENADLFWAARGSGPGFFGVVTAFRLRTRPRFRELTRSAYVFPSELAAEVLSWYHVARHDLPASVELAAVGSTPPGSDAPVLTVDAVSFDGGPASLAALDSSPVVARASARTVAEPVDFAELQAEQLRGNPENHRYAADNAFLSGSASELVPALVPAFTELPTPRTFTVLGDFTPLVARRPPDMAVSLQTDLYFAAYAIGTTPADDVLSRTWLDRTMSRLAPHSVGCYLGDSDLAVRADRIMSDAAWSAFRRIRAARDPEGRFPGYLGDPAQ	MPEQHPPITETTTGAASNGCPVVGHMKYPVEGGGNQDWWPNRLNLKVLHQNPAVADPMGAAFDYAAEVATIDVDALTRDIEEVMTTSQPWWPADYGHYGPLFIRMAWHAAGTYRIHDGRGGAGGGMQRFAPLNSWPDNASLDKARRLLWPVKKKYGKKLSWADLIVFAGNCALESMGFKTFGFGFGRVDQWEPDEVYWGKEATWLGDERYSGKRDLENPLAAVQMGLIYVNPEGPNGNPDPMAAAVDIRETFRRMAMNDVETAALIVGGHTFGKTHGAGPADLVGPEPEAAPLEQMGLGWKSSYGTGTGKDAITSGIEVVWTNTPTKWDNSFLEILYGYEWELTKSPAGAWQYTAKDGAGAGTIPDPFGGPGRSPTMLATDLSLRVDPIYERITRRWLEHPEELADEFAKAWYKLIHRDMGPVARYLGPLVPKQTLLWQDPVPAVSHDLVGEAEIASLKSQIRASGLTVSQLVSTAWAAASSFRGSDKRGGANGGRIRLQPQVGWEVNDPDGDLRKVIRTLEEIQESFNSAAPGNIKVSFADLVVLGGCAAIEKAAKAAGHNITVPFTPGRTDASQEQTDVESFAVLEPKADGFRNYLGKGNPLPAEYMLLDKANLLTLSAPEMTVLVGGLRVLGANYKRLPLGVFTEASESLTNDFFVNLLDMGITWEPSPADDGTYQGKDGSGKVKWTGSRVDLVFGSNSELRALVEVYGADDAQPKFVQDFVAAWDKVMNLDRFDVR	59.86	gnl|BL_ORD_ID|1955|hsp_num:0	1176			1131	1458	isoniazid
BGC0000950.1|Napsamycin_8 # 5930 # 8560 # -1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GGC;rbs_spacer=5bp;gc_cont=0.727	BGC0000950.1|Napsamycin_8 	5930	8560	-	Loose	1000	127.487	almE	26.0	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGAACGAGACGAACGACATATCAGGTTCGTCAGCGAGAGCGAGATTCCCGATTGATGCCCGTCACACCCGCTGGATGGAGGATGGCAAGTCGATGACCACGGACCACGCCGCACTGCCCACGGGGTGCCACGCGCGCACTCCGGCTCCGCCGCCGGACGCAGCGTCCCTGCCGGACGATCCGCCCCTGCCGCACGAACTCGCCCTGCCGACGGACCGGTCGCGGCCGGCCCACCCCGCGCCGGCCGTGGAGCTGCACCGGTTCGACCTGACTCCCGGGATCCACCGTGCCCTGCTCGCCACCGCCGGGGCCGCCCGGGCGTCGCTGCCTACGGCGCTCCATGCCGCCGTGGCCGCTCTGCTGACCCGGCTGGGGGCCGGCGTCGACATCCCGATCGCGGCACCGGCGGACTCCCCGGCCCGGTACCTCAGCCTGCGGATCGGAACAGACGGGGACCCGAGCCTTCGTGAGCTTCTCGTACGGGCTCGGGAGGCGGGTCGCACGGCCCGCGCGAGGCAGGACGTCGCCACGCGACGCCGGACGGACGACGCCGACCCGGTGCGGCGCGTCGGAAGCGGTCCGGCGGCCCAGGTGGCCGTGCTCGTCGTCGACGAGCACGGCCCCGGCTGCGACCCGACGGGCACGACCGGCTTCGACCTCGCCCTCACCGCGACGGAGCGACGGGGGGCCGAGGGCGAACCGGCCGGCATCGCCTGCGCACTCGCCTACGACTCCGAGCTCTTCGACCCCGGGACGGCCGCTGCGCTGGCGGCGCGTCTGGTCACGCTTCTCACGGCATTCGCCGACGTCCCGGACACCGCGCTGTCGCGCGTGGAGCTGTTCTCCGACGACGAGCGCCGGGCCTGGCTGGCGATGTCCAGTGGAACCGAGCATGCGATCGGTGAGTGCACCCTGGTCGAGCTGTTCGAGACACGGGTCCGGGCGACGCCGGACGCCGTGGCGCTGGTGTGCGGCGACCGTTCGCTGACGTTCGCCGAACTGAACGGGCGGGCCAACGCCCTGGCCCGGCGGCTGATCGGGGCAGGTGTCCGCTCCGAGGAGCCGGTGGCCCTCCTGATGGACCGGTCGGCGGAGCAGATCGTCTCGATCCTGGCGATCCTCAAGGCGGGCGGTTGCTACCTCCCGCTGCACCTGGCGCATCCGGCGCGACGCATGACCGGCGCCCTTGAGGCTGCTGAGGTCAGGATCCTGCTGACCGATGGTTCGCACGCCGGCCACGAGGTCGCGAGGGCCGCCGGGACGACACTCCTCGTGACGGCGGACGGTCCGGCCGCGGCGGACGGCGGTGACCTCGACCGCAAGCCGCTGCCCGAGCAGGCCGCGTACATCATGTTCACCTCCGGCTCGACCGGCACCCCCAAGGGCATCCTGGTGCCCCACCGGAGCGTGGTGCACCTGGCCCTCGACAGATGCTGGGGCGAAGGCGTGCTGGAGCGGATGCTGGTGCACTTCTCCGCCGCGGTCGATCCGTCGACGGGCGAGATCTGGGCCCCGCTGCTCAGGAACGGCAGTCTGGTGATCGCACCGCCCGGCGATATCGACGCGCAGGAGCTGCGGGAGCTCGTCTCCCGCTACGGCGTCACCGGCGCCATCTTCCCCGGCGGGCTCTTCCGGATGCTTGCCGACGACGACCCGGCCGCGTTCGCGGGGTTGACCGGCGTCTACACGGGCGGCGAGGTCATTTCGCCGGTCGCGGTGCGCAAGGTGCTCGACGCGGCTCCCGGTCTCCTCGTGCACCCCCTGTACGGACCGACCGAGGCGACCCTGGCCGTTACCTACCACACGATTCGGCAGGCAGGGGAGCTGGCGGGAGATGTCCCCCTCGGCCGGCCGATGGACAACCGGCACGTCTATGTCCTGGACGAGCATCTCAACCCGGTGCCGCCCGGCACCGTCGGCGAGCTGTACCTCGGCGGTGCGGGCCTGGCCCGCAGCTACGTCGGCAGCCCGGTTCTGACGGCCGAACGGTTCGTCCCGGATCCCTTCCAAGGGGTGGGTGCCCGGATGTACCGGTCGGGGGATCTGGCCCGCTGGACGCGTGACGGCGTCCTCATGTTCGTGGGCCGCACCGACGAGCAGGTCAAGGTACGCGGCTACCGCATCGAGCTCGGGGAGATCGAGACCGCCCTGGCCCGGCAGGAAGGCGTCCGGAGGGTCGCCGTCGTCGTCCGGGAGGACCAGCCCGGCGACGAACGACTGGTGGCGTACCTGGTGCCGGGCGCGGGAGCGGCACCGGACCCGGAGGCGCTGGCCGAGGAGCTGCGCGCCACTCTGCCGGCGTACATGGTGCCCTCCGCCTTCGTCGCCCTGCCGGAGCTACCGCTGACGCCGAACGGGAAGACGGACCGTACGGCCCTGCCGGCGCCGGACTACGGCGGCGGCGCGGGCCAAGGCCCCCGCACGGCCGACGAGGAGCGTCTGTGCGCTCTGTTCGCCGAGGTCCTGGGGGTGGAACGGGTCGGCGTGGACGAGGGATTCTTCGCCCTGGGCGGGGACTCGCTGTTGGCGACCCGGCTGAGGACCAGGATTCGGAGCGCGCTCGGTGTCGACCTCAGGGCGCGAGTGCTGTTCCGGCACCCGACCGTCGCCGAGCTCGCGCGGCTGCTCTGA	MNETNDISGSSARARFPIDARHTRWMEDGKSMTTDHAALPTGCHARTPAPPPDAASLPDDPPLPHELALPTDRSRPAHPAPAVELHRFDLTPGIHRALLATAGAARASLPTALHAAVAALLTRLGAGVDIPIAAPADSPARYLSLRIGTDGDPSLRELLVRAREAGRTARARQDVATRRRTDDADPVRRVGSGPAAQVAVLVVDEHGPGCDPTGTTGFDLALTATERRGAEGEPAGIACALAYDSELFDPGTAAALAARLVTLLTAFADVPDTALSRVELFSDDERRAWLAMSSGTEHAIGECTLVELFETRVRATPDAVALVCGDRSLTFAELNGRANALARRLIGAGVRSEEPVALLMDRSAEQIVSILAILKAGGCYLPLHLAHPARRMTGALEAAEVRILLTDGSHAGHEVARAAGTTLLVTADGPAAADGGDLDRKPLPEQAAYIMFTSGSTGTPKGILVPHRSVVHLALDRCWGEGVLERMLVHFSAAVDPSTGEIWAPLLRNGSLVIAPPGDIDAQELRELVSRYGVTGAIFPGGLFRMLADDDPAAFAGLTGVYTGGEVISPVAVRKVLDAAPGLLVHPLYGPTEATLAVTYHTIRQAGELAGDVPLGRPMDNRHVYVLDEHLNPVPPGTVGELYLGGAGLARSYVGSPVLTAERFVPDPFQGVGARMYRSGDLARWTRDGVLMFVGRTDEQVKVRGYRIELGEIETALARQEGVRRVAVVVREDQPGDERLVAYLVPGAGAAPDPEALAEELRATLPAYMVPSAFVALPELPLTPNGKTDRTALPAPDYGGGAGQGPRTADEERLCALFAEVLGVERVGVDEGFFALGGDSLLATRLRTRIRSALGVDLRARVLFRHPTVAELARLL	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	157.55	gnl|BL_ORD_ID|4935|hsp_num:0	5928			75	1629	colistin A; colistin B
BGC0000950.1|Napsamycin_9 # 8505 # 8870 # -1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GGC;rbs_spacer=8bp;gc_cont=0.604	BGC0000950.1|Napsamycin_9 	8505	8870	-	Loose	900	25.7942	lmrB	44.44	3002813	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGACCACGTACCGGCACACCGTCGAGGACGCGGATGTCTTCAGCAAACACGGCATCGAGCTGACGGTCTACGGGCAACGCGACCCGTCGGCCACGGTTGTGCGCGTGCAGGTGGAACGAGGGCATTTCCAGGAGTTCTCCAATTCCCGAAGTTCCTACATCTATTACATCGTCAGCGGTCGGGGGGTGTTCCACCTGAACGACGAGGCGATCGCCGTCGGTGCCACCGACCTGGTAACCGTCCCGCCGAACACCCGGATCCACTATTTCGGCACGATGGAGATGGTCCTCACTGTGGCGCCGGCATTCGATGAACGAGACGAACGACATATCAGGTTCGTCAGCGAGAGCGAGATTCCCGATTGA	MTTYRHTVEDADVFSKHGIELTVYGQRDPSATVVRVQVERGHFQEFSNSRSSYIYYIVSGRGVFHLNDEAIAVGATDLVTVPPNTRIHYFGTMEMVLTVAPAFDERDERHIRFVSESEIPD	METTAKASQQYKVMPIMISLLLAGFIGMFSETALNIALTDLMKELNITAATVQWLTTGYLLVLGILVPVSGLLLQWFTTRQLFTVSLIFSILGTFIAALAPSFSFLLAARIVQALGTGLLLPLMFNTILVIFPPHKRGAAMGTIGLVIMFAPAIGPTFSGLVLEHLNWHWIFWISLPFLVLALVFGIAYMQNVSETTKPKIDVLSIILSTIGFGGIVFGFSNAGEGSGGWSSPTVIVSLIVGVVGLILFSIRQLTMKQPMMNLRAFKYPMFILGVIMVFICMMVILSSMLLLPMYLQGGLVLTAFASGLVLLPGGILNGFMSPVTGRLFDKYGPKWLVIPGFVIVTVVLWFFSNVTTTSTAVLIIILHTCLMIGISMIMMPAQTNGLNQLPREFYPDGTAIMNTLQQMAGAIGTAVAVSIMAAGQHDYMSTVKNPADPAVIPQALTAGVQHAFVFAMIVAIIGLIGAFFMKRVKVDH	25.37	gnl|BL_ORD_ID|540|hsp_num:0	592			378	459	
BGC0000950.1|Napsamycin_10 # 8874 # 10421 # -1 # ID=1_10;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.699	BGC0000950.1|Napsamycin_10 	8874	10421	-	Loose	2000	26.1794	Bifidobacterium adolescentis rpoB mutants conferring resistance to rifampicin	28.26	3004480	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic target alteration; antibiotic target replacement	rifamycin-resistant beta-subunit of RNA polymerase (rpoB)	GTGGTGATCCGCCGATGTATCGCCGACGCGGTCGGCCGCCACGACGCCTTCCGGATCCGGATGTGTGACACCGATTCCGGGATCCCCGCGCAGGAGGTCGTCGCGGATATCTCCGTGGAGGTCTCCCAGTACGACCTGCGCGACGCCGACGACCCCGCGGTACGGCGGGGGGAACTGCTCCGCGGGCAGGTCAGCACCGCCTTCGACCTACGGACCGCGCCGCTCGTCCGCTGGATGCTGCTGCACCTGGCCGACGGTCACTGGCAACTCGCCATGACCGAACACCACCTGGTCCACGACGGCCGGTCCACCGTGATCTTCCTCGGCGACGTGCTCGACCAGTACGCGGCCGAGATGTCCGGCGGAGACCACGTCCCGGAGGCTGCCCCCTCGTACGAGGAGTACGTCGCCCACACGGGCTCGGACGAGTACCGTGCGCGGGTCGCCGCCGACGTCGCCTGGTGGGCGGAGCGGCTCGACGGTGCCCGGTTCAGCATCGACTTCCCCACCCTGGGGACCCGGCGCTCGGCCCTGTTCGATCACCGCGGCGGGCAGTTCCGGCAGGTGCTCTCCGCCCCGCTCATGGACCGGGTGCGGGATGTCGCCCAGGAGAGTGGTCACACGGTCTTCGCCACGCTGCTTGCCGTCTACTCCGAACTGTGCCGCCGCCACTCCGGGCAGGACGAACTGGTCATCGGCATGCCGCTGGCCAACCGCCCGGTGGAGTTCGAGCACACGGTGGGGATGATGGTCGGCGCCGTACCGCTTCGGCTGGCGATCGACCCCCTGGCTCCGGGCAGCGACCTCGCCGAGGAGGCCATGACGGCGGTCTTCGACGCCATCGACCATGAGTCGGCTCCGATCCAGGACCTGGTGACGGCGCTCAAGCGCAGCAGCAAAGGGCTGGGCAACCCGCTTTTCAACATCATGTTCGCCATGCACGACGCCCCCTGTCCGCCCGTGAAGATCCCCGGCCTCTCGGTCAACATGGAGATCGCCGTGAGCGCCGGCAGCACCAAGTTCGACCTGAGCGTCGTGGTCATGCCGGACAAGGTCCTGCAGGCGGACCACGGCGACCACGGCTACGAACTGGTCTGGGAGTACTCCACTCAGATGTTCGGGCCCGAGGACGTGGAGACGCTCGCCACCGGATTCGAGACCCTGCTCCGCGCCTACGTCGCCAGGCCTTCCGCGCCGATCGGCACCTTGGCACCGGCCGTGGCCGCGCGTCCGGCACGCGACGCCCGCGACAAGGACGAGGAGTTCGGTGCGGCGGAGGTGGCGCCGCGCGCCGGGGACGCTCCGGCCACCGACGCCGGAACGCCTTCCGGCTCGCTGTGGCTGCAGGCGTTCCGGCACATCCTGGAGCGCGACGACATCGACGAGGACACCGACTTCTTCCAGGCGGGCGGCTATTCGCTGCTCGTGCCGCTGCTGGTGGCGCACTACGAGACGCTCGCGGGCCGACGGACTCCGCCGAGTCTGGTCTTCGAGTTCTCGTTGCCGCGAGAACTGGAGGCGGCGACGGCCGCGATGGCGGGGCGCTGA	MVIRRCIADAVGRHDAFRIRMCDTDSGIPAQEVVADISVEVSQYDLRDADDPAVRRGELLRGQVSTAFDLRTAPLVRWMLLHLADGHWQLAMTEHHLVHDGRSTVIFLGDVLDQYAAEMSGGDHVPEAAPSYEEYVAHTGSDEYRARVAADVAWWAERLDGARFSIDFPTLGTRRSALFDHRGGQFRQVLSAPLMDRVRDVAQESGHTVFATLLAVYSELCRRHSGQDELVIGMPLANRPVEFEHTVGMMVGAVPLRLAIDPLAPGSDLAEEAMTAVFDAIDHESAPIQDLVTALKRSSKGLGNPLFNIMFAMHDAPCPPVKIPGLSVNMEIAVSAGSTKFDLSVVVMPDKVLQADHGDHGYELVWEYSTQMFGPEDVETLATGFETLLRAYVARPSAPIGTLAPAVAARPARDARDKDEEFGAAEVAPRAGDAPATDAGTPSGSLWLQAFRHILERDDIDEDTDFFQAGGYSLLVPLLVAHYETLAGRRTPPSLVFEFSLPRELEAATAAMAGR	MAEATTNTTTIIARADQHDIDLHKASDRVNFGSIREPIDVPYLLGVQTDSFDWLIGNERWQKRVQEDLENGTNTVPHTSGLDEVFQEISPIENFAQTMSLTFSDPYFEEPRHTVQECKEKDYTYSAPLYVNAEFENGDTGEIKSQTVFMGDFPLQTPHGTFIIGGTERVIVSQLVRSPGVYFDRSQDRTSDKEVFGAKIIPSRGAWLEFEIDKRDVLGVRVDRKRKQSAIVFLMAIGMTKDEIADAFKDYPLVMDALAKETVQTQDEALTDLYRKIRPADTPTPEAGKNLLDSFYFNTKRYDLARVGRYKINRKLGLEKDVNDRSLSREDIIATIKYLVTLHAGETKFPGKRDGQDVDLRVDVDDIDHFGNRRIRQVGELIQNQLRTGLSRMERVVRERMTTQDPEAITPQSLINIRPVNATIKEFFGTSQLSQFMDQNNPLAGVTNKRRLSALGPGGLSRDRASMEVRDVHPSHFGRMCPIESPEGPNIGLIGSLATFGRINPFGFIETPYRKVVNGHVTDEVEYMTADRDAEHVIAQANQELDENGNFVKKQALARVGEEEAVDVPVSSVDYMDVSPRQMVSVGASLIPFLEHDEGHRALMGTNMQRQAVPLIESERPLVGTGAEWRAAVDSGDVILAEKPGVVTYVSADIIRTMNDDGTTSSYKLAKFQRSNQTTCYNQVPLIHDGERVEAGTVLADGPATQKGEMALGKNLLIAFMPWNGYNYEDAVIISQRLVQDDTLSSIHIEEYEIDARETKLGAEEITRDLPNVGEDAVANLDERGIIRIGAEVEAGDILVGKVTPKGETELTPEERLLRAIFGEKSREVRDTSLRVPHGETGTVIAVKEITREDAEEDGDELPNGVNQMIRVYIAQHRKITQGDKLSGRHGNKGVISRILPEEDMPFLADGTPVDIMLNPLGVPSRMNLGQVLELHLGWIAHAGWDISLDPDAEAAWKKYVPQGAEKGAPGTPVATPVFDGVRPETIKGLLSCTLPDRDGNKLVGPDGKATLFDGRTGEPFPKPISVGYMYMLKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMEVWALEAYGAAYTLHEMMTTKSDDVDGRVRVYGAIVKGENLPPAGIPESFKVLLKEMQSLSLNVEVLNADGVAIDMKEEDDDPSTSSDDLGFNIGARPDAAAKEDQVAEEPEFQ	43.42	gnl|BL_ORD_ID|4719|hsp_num:0	2914			2487	2625	rifampin
BGC0000950.1|Napsamycin_11 # 10437 # 10553 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.615	BGC0000950.1|Napsamycin_11 	10437	10553	+	Loose	750	20.7866	mefE	30.77	3000614	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAAATTCGACCACCGCGGTGGCGTGATAGGCGCGGCTCTCCGGAAGCACCTGCTGCTGGAGCCAGACGATTTGCTGTGCGGCGCTGAGCGGAAACACCGGGTCTCCTTCTTCTGA	MKFDHRGGVIGAALRKHLLLEPDDLLCGAERKHRVSFF	MKIDKKNEAFLIVSRGISRIGDIMFDFANNTFLAGLNPTSLSLVAVYQSLESVIGVLFNLFGGVIADSFKRKKIIIVANILCGIACIILSFISQEQWMVFAIVITNIILAFMSAFSGPSYKAFTKEIVKKDSISQLNSLLEITSTIIKVTIPMVAILLYKLLGIHGVLLLDGFSFLIAASLISFIVPVNDEVVTKDKMTIGGVLNDLKIGFKYIYSHKTIFMIIILSAFVNFFLAAYNLLLPYSNQMFGEISDGLYGVFLTAEAIGGFIGAILSGVINKTLSSKRLMVFLSCSGLMLMLSTPLYFLFQNFIILAFSPALFSLFISIFNIQFFSIVQREVDTEFLGRVFGIIFTVAILFMPVGSGFFSVVLNPNNTFNLFIIGVSITILSLIFSTLLKRYDKNS	9.43	gnl|BL_ORD_ID|1283|hsp_num:0	1401			171	249	
BGC0000950.1|Napsamycin_12 # 10789 # 13350 # 1 # ID=1_12;partial=00;start_type=GTG;rbs_motif=GGC;rbs_spacer=7bp;gc_cont=0.728	BGC0000950.1|Napsamycin_12 	10789	13350	+	Loose	1000	123.25	almE	25.94	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	GTGACGGAGAAGGCCGAGGCAGTCCGCGGTCGGCAGGCACACGGGGTGGGGCCGGTACGGCCGCTCCCCGACCGCCGCGCCCACGAGATCTTCGAGGAGTGCGCGCGGGCGACGCCGTCGGCCGTCGCGGCCGTCCACCGTGGCACGCGGTGGACCTACGCGGAACTCGACGCCGCTGCGAACCGAGTGGCCGGAGCCCTTCTCTCTGCCGGGCTGCGGCCCGAGGGCGTGGTGTCGGTCATCAGCCACCGCTCGCTCGACTGGCTGGCTGCGATGCTCGGCATCTTCAAGGCGGGCGGGGCCTATCTGCCGATTGATCCGGCCTACCCCGACGAGCGGATCGCCGACCTGCTGCACCGCAGCGGGAGCCGGCTGGCCCTTGTCGAGGACGATGTGTCGGAGCGCCCGCTCAAGGAGGCGGCCGTACGGGCGCTCCCGCTGGCTCCGGCAGCAGCCGACGAGGCGCAGCCCGCCCGTGTCGGGGACGGGGCGCTTGCCTACATCTACTTCACCTCCGGCTCCACGGGGGCGCCGAAGGGCGCCGCCTGCGAACACGCCGGCATGCTCAACCACCTGCTGGCGAAGATCGACACGTTCGAGATCGCGGCGGGCACTGCCGTGGCCCAGACCGCGTCCCAGTGCTTCGACATCTCTCTGTGGCAGGCGCTCGCGCCGCTCCTCGTCGGCGGCAGCACCGTGATCATCGATCCGGAGCTGATGCTCGACGTCCCCGCGCTCCTCTCCCTCCTGGCAGCGGAGAATGTCGGCGTCCTCCAGCTCGTCCCCAGCTACCTGGACGTGATCGTCAGCAGGCTGGAGCGGGGCGACCGTGCGCCCGACTCGCTGCGCATGCTCGGCGTCACCGGCGAGGCGGTGAGCCGGCAGGTGCTCACCCGCTGGTTCAAGCAGTGTCCCGACGTGCCCGTGGTCAACGCCTACGGCGCTACCGAGGCATCGGACGACACGACACACGAGGTCATCCGCGGCATGGCGGACGATGAGCAGGTCACCGTGGGCGTGCCCATCGCCAACGTCCTTGTCGACGTCGTCGGCGAGGACGGGCTCCCTGTGGCGGACCACAGCATCGGGGAGATCACGTTCTCCGGGGTGTGCGTCGGCCGGGGCTACATCAACGATCCGGAACGCACCGCAGAGGCCTTCGGCGACGATCCGGTCCGCCCCGGGCTGCGCCGCTACCGCACCGGTGACTACGGACACTGGCTGTCCGACGGGCGGCTGCGGTTCGTCGGCCGACGGGACGAGCAGGTGAAGATCAGCGGGGTCCGGGTCGAGGTCGGCGAGGTCGAGGCGCAGCTCCTGCGGGTGGCCGGGGTGCGGGCGGCATGCGTGATCGTGATGCCGGACGGCGCGAGCAAGCGCCTTGCGGGCTTCTACACGGCCGAGCAGGCGATACCGACGGTCCGTGAGCTGCTGGCCGATCGGCTTCCGACGCAGTTGGTGCCGCGTACGCTGCGCTGGCTGCCCGAGTTCCCGCTCACCGACAACGGCAAGGTCGACAAGCGGGCCTTGGCGGAGCTGGAGACCAGCAGTGCGAGCGGCAACAGCGTGACGCCGCCGCGGACCGCCGCGGAGCGGCGGATCGCCACCGTGTGGGCGGAGGTGCTGGGCCTGCCGCTCGACGAGGTCGGCCGCAACGACGACTTCTTCGCCCACGGCGGCGGGTCGCTGGCGGCGGTGCGGCTCGTCGTGCAGCTCGGCGGGCTCATCTCGCTCGTGGACCTCATGGCCAACCCGGTGCTGGCCGATCTGGCCGCCGCTGCCGAGGGTGCCGGTCCGGCCGAGGCCCCGCTGCTCCAGCCGCTGTCGGTGCCGAAGGACGCGACCACGGCGCTCGTCTGCGTACCGTACGAGGCGGGCAACGCGCTCAACTTCGAGGCCATGGCCCGGGCGTTGTCCGCCGCGGACGTGGCGGTGTACGCGGTGGAGCTGCCCGGCCACGACTTCGCCCGGCCGGACGAGGAGCTGGCCGGAGTCGACCGGGTCGCCGGCCCGCTGACCCGGGAGATCCTCGACCGGATCGAGCTGCCCGTGGCGCTGTGGGGGCACGGGGCGGGCGTGGCGCTCGCGCTGGAGACCGCCCGGTCGCTGCGGGAGGCCGGTGCACCTCCCCGCCACCTCTTCCTGGCCGCCGGGATCGAACGGGAGCCCACCGACGGCGGACCGGCCGGTGGCGGAACAGCTGCCGCCGGATCGACCGACATCGGCGCCTGGCTGCGTGACGCCGGCGCGCTCACCGACGTCGACCAGTCGCGTTCGAGCCGCGGCGAGTTGATCGAGCGCGCCTACCGGCACGACCTCCGCGAGGCGGAGCGGTACCTCGGCGCCTTCTCCGGGACCCTCGACCTGCCCGCGACGATCGTGGCGATCCCTGCGGCTCCCGGTGAGGGCGAGGCCACGGCGCGCTGCGCGGACGTACTCCCCGGGGCGCGGATCACCTGGTTCGCGGAGCCGAGCCGTTATCTCGTCCGCAGTCACCCCGCCGCCGCGGCGGAGATCGTCACCGCGACCCTCGCGGCCGCTGAGGAAGGCAGCACCCGTTGA	MTEKAEAVRGRQAHGVGPVRPLPDRRAHEIFEECARATPSAVAAVHRGTRWTYAELDAAANRVAGALLSAGLRPEGVVSVISHRSLDWLAAMLGIFKAGGAYLPIDPAYPDERIADLLHRSGSRLALVEDDVSERPLKEAAVRALPLAPAAADEAQPARVGDGALAYIYFTSGSTGAPKGAACEHAGMLNHLLAKIDTFEIAAGTAVAQTASQCFDISLWQALAPLLVGGSTVIIDPELMLDVPALLSLLAAENVGVLQLVPSYLDVIVSRLERGDRAPDSLRMLGVTGEAVSRQVLTRWFKQCPDVPVVNAYGATEASDDTTHEVIRGMADDEQVTVGVPIANVLVDVVGEDGLPVADHSIGEITFSGVCVGRGYINDPERTAEAFGDDPVRPGLRRYRTGDYGHWLSDGRLRFVGRRDEQVKISGVRVEVGEVEAQLLRVAGVRAACVIVMPDGASKRLAGFYTAEQAIPTVRELLADRLPTQLVPRTLRWLPEFPLTDNGKVDKRALAELETSSASGNSVTPPRTAAERRIATVWAEVLGLPLDEVGRNDDFFAHGGGSLAAVRLVVQLGGLISLVDLMANPVLADLAAAAEGAGPAEAPLLQPLSVPKDATTALVCVPYEAGNALNFEAMARALSAADVAVYAVELPGHDFARPDEELAGVDRVAGPLTREILDRIELPVALWGHGAGVALALETARSLREAGAPPRHLFLAAGIEREPTDGGPAGGGTAAAGSTDIGAWLRDAGALTDVDQSRSSRGELIERAYRHDLREAERYLGAFSGTLDLPATIVAIPAAPGEGEATARCADVLPGARITWFAEPSRYLVRSHPAAAAEIVTATLAAAEEGSTR	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	153.42	gnl|BL_ORD_ID|4935|hsp_num:0	5928			84	1635	colistin A; colistin B
BGC0000950.1|Napsamycin_13 # 13347 # 14870 # 1 # ID=1_13;partial=00;start_type=TTG;rbs_motif=GGC;rbs_spacer=8bp;gc_cont=0.731	BGC0000950.1|Napsamycin_13 	13347	14870	+	Loose	910	28.4906	mtrE	29.41	3000812	protein homolog model	n/a	n/a	macrolide antibiotic; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	TTGAAGCTGACCGGTCGGCTCGCGGCCACGCCGGACGACTTCATCCGGCAGGAGTTCCTGGAGCCCCAGTTCACGCACGAGGTCGCCCACCTGCTGCGCTGGTACGTCCTGATCGAGAAGGCGCTGCTGCGCGAGTACCGCCGCCTCGGCGTACTGGCGGACGAGTCCGTCCACCGACTCGCGGCGGCGCTCGACGGGCTGACCCCGGAGCGGCTGACCGCCGGCGCCGGGGCGGCCCTCACCGACATCGCGCTGGCGATGGAGACCGGCGTCACCCGGGCCCTGCCGGAGCCCGTGCCCGCCTGGCACGTCGACCGCAGCCGCAACGACCTCCAGGCCACGGCCCAACTTCTTTACGGACGCGAGCAGGTGAGCGAGATCGCGGCCCTGCTCGGAGAGCTGGCCACGGTCGCGCACGAACGGGCGTCGCGCGACATCACCTCGCCGATGCCCGGGTACACGCACCTCCAGTCGGCGCAGATCATCACGCCGGGCTTCTACCTCAGCGCCGTGGTGGAGCACGCGCTGAGCGTGTCGTCCCGGCTGCTCGGCACGTACGACCGGATCAACCGCTCGCCGCTCGGCGCAGGTCCGATGGCCGGGCAGGAACTGAGCTGGGACCGTGCCTGGCTGGCACGGGCAATCGGCTGCGACGGACCGGTCCCGCACGCGCTGCCCGCGGTCGCTTCGCGGGAATGGCTGCTCGACGTCGCCGCCGACCTCGCCTCGGCGGGCGTAGGGTTCAGCCGCTTCCTCACCGACCTCATGGCCTGGTCGTCGAGCGCGTACGGACTGGTCGAGCTGCCGGACGAGCTCGCAGGCATCTCCGCGGCCATGCCGCAGAAGAAGAACTACCCGCTGCTGGAGCGGCTGCGCGGGCGCACCGCGCACCTCACGGCCTTCTACGTCGACTTCGCCGCCGGCCAGCGGAACACGCCGTACAGCAACATGGTGGAGGTCTCCAAGGAGGCCGGCCTGCACGCGAGCAACCTGTTCGGCGCGACGCGCGCGGTACTGACCGGTTTCACCCTGGTCCTCGACCGGCTCCAGTGGCGCACCGACCGGATGCGCGCCGTCTGCGAGGAGGACCACTTCGGGGGCTTCGGCCTGGCCAACGAGCTGACCCTGCGGGCCGGGTTGCCGTGGCGTACCGCGCAGGTCGTCGCCGGCCGGTACGTCACCGCGGTACTCGCCGAGGGCGACGGGCTTCCGGGACACAGCAGTCCGGCGGCGCTCGGCAAGGCGGCTCTGGAGGCGGGGCATCCGCTGGACGACCCGGCCTCGTTCCTGACGCACTCCGCGGACGTGGACGCGCAACTGCGCGCGAAGGTGTCCGCGGGCTCGACGAGTCCGGACGCGATGACGGCGCTGCTGGCCGAGCAGCTCACGCGGATCGATGCGCTCCGGGCGGAGTGGGACACGCGCCGGGCCGCGGTCCGGGACGCGCTCGCCGCCACCGACGCCGCCGTCTCGCCCCCGGCCGCCGACGCCGCCCGCTCGTCCGGGGCCGGGGGCGCCGCATGA	MKLTGRLAATPDDFIRQEFLEPQFTHEVAHLLRWYVLIEKALLREYRRLGVLADESVHRLAAALDGLTPERLTAGAGAALTDIALAMETGVTRALPEPVPAWHVDRSRNDLQATAQLLYGREQVSEIAALLGELATVAHERASRDITSPMPGYTHLQSAQIITPGFYLSAVVEHALSVSSRLLGTYDRINRSPLGAGPMAGQELSWDRAWLARAIGCDGPVPHALPAVASREWLLDVAADLASAGVGFSRFLTDLMAWSSSAYGLVELPDELAGISAAMPQKKNYPLLERLRGRTAHLTAFYVDFAAGQRNTPYSNMVEVSKEAGLHASNLFGATRAVLTGFTLVLDRLQWRTDRMRAVCEEDHFGGFGLANELTLRAGLPWRTAQVVAGRYVTAVLAEGDGLPGHSSPAALGKAALEAGHPLDDPASFLTHSADVDAQLRAKVSAGSTSPDAMTALLAEQLTRIDALRAEWDTRRAAVRDALAATDAAVSPPAADAARSSGAGGAA	MNTTLKTTLTSVAAAFALSACTMIPQYEQPKVEVAETFQNDTSVSSIRAVDLGWHDYFADPRLQKLIDIALERNTSLRTAVLNSEIYRKQYMIERNNLLPTLAANANGSRQGSLSGGNVSSSYNVGLGAASYELDLFGRVRSSSEAALQGYFASVANRDAAHLSLIATVAKAYFNERYAEEAMSLAQRVLKTREETYNAVRIAVQGRRDFRRRPAPAEALIESAKADYAHAARSREQARNALATLINRPIPEDLPAGLPLDKQFFVEKLPAGLSSEVLLDRPDIRAAEHALKQANANIGAARAAFFPSIRLTGSVGTGSVELGGLFKSGTGVWAFAPSITLPIFTWGTNKANLDVAKLRQQAQIVAYESAVQSAFQDVANALAAREQLDKAYDALSKQSRASKEALRLVGLRYKHGVSGALDLLDAERSSYSAEGAALSAQLTRAENLADLYKALGGGLKRDTQTGK	108.57	gnl|BL_ORD_ID|409|hsp_num:0	453			405	576	erythromycin; penicillin; azithromycin
BGC0000950.1|Napsamycin_14 # 14867 # 15790 # 1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=GGC;rbs_spacer=5bp;gc_cont=0.732	BGC0000950.1|Napsamycin_14 	14867	15790	+	Loose	800	31.5722	PDC-173	50.0	3005306	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin	antibiotic inactivation	PDC beta-lactamase	ATGACGAGCCGGCAGCTCATCGGCCCGCCGGCCGGGCGCGGGAGGACACCGGCGCGCGCCGTCGCCGTCAGCTCCGCCTTCGGTACCTTCGGGGAGCTCCTCCAGGGCGCCCTGCCCGACGGCGGACCCGACTTCCTGGTCACCCTGCCCATCGCCCGATGGGCCACGGCGACGTTCGAGTACCGGAGCGCCGACGACTCCGTCGAGGTGTCCCCGGCGACGAAGACGAAGGCCCGCCAGGTCGCCGAGGCCGTGCTCGCCCGGTACGCCGACGGCGGCGGGACGCTGCGGCTCAGCGGCGCGCTGCCGGAGGGCAAAGGCCTGGCGAGTTCGTCGGCCGATCTGGTGGCGACGGCGCGCGCTGTGGCGAGCGCGGTCGGCGTCGAGCTGCCGCCCCGGGTCATCGAGGACGTGCTGCGCCGGATCGAGCCGACAGACGGCGTGATGTATCCGGAGGCGGTGGCGTTCCGGCACCGCGAGGTCAGGCTGCTGGGCAGGCTCGGCGCCCTGCCGCCGATGACCATCGTCGGCATCGACGAGGGCGGCACCGTGGACACGCTCGCGTTCAACCGGATCCCCAAGAACTTCACCGACGCGGAGCGGGACGAGTACGCCCTGCTGCTGGACAGGATCCGGACGGCGGTGCGGGCCGGTGACGCGGCGGCCATCGGGCAGGTGGCGACCCGCAGCGCCCACCTCAACCAGCGACTCTGCCGGAAGCGGACGCTGAACGCGATGACGGCGCTGAGCGCGGAGGTCGGCGGGGTCGGGGTGGTGACCGCGCACAGCGGGTCCACGATCGGGCTGCTGCTGCCGCACGACGTCCCCGGTTTCCGGAGCCGGCTGGCCGAGGCCATCAACCGGTGCGGTCAGCTCGTCCATCGCGAACGGGTGCTCTGTTACCAGACCTTGGTGTCGAGCTGA	MTSRQLIGPPAGRGRTPARAVAVSSAFGTFGELLQGALPDGGPDFLVTLPIARWATATFEYRSADDSVEVSPATKTKARQVAEAVLARYADGGGTLRLSGALPEGKGLASSSADLVATARAVASAVGVELPPRVIEDVLRRIEPTDGVMYPEAVAFRHREVRLLGRLGALPPMTIVGIDEGGTVDTLAFNRIPKNFTDAERDEYALLLDRIRTAVRAGDAAAIGQVATRSAHLNQRLCRKRTLNAMTALSAEVGGVGVVTAHSGSTIGLLLPHDVPGFRSRLAEAINRCGQLVHRERVLCYQTLVSS	MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALTQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLPEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR	78.92	gnl|BL_ORD_ID|3010|hsp_num:0	4038			651	753	
BGC0000950.1|Napsamycin_15 # 15808 # 18075 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.729	BGC0000950.1|Napsamycin_15 	15808	18075	+	Loose	250	40.0466	vanG	29.84	3002909	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; Van ligase	ATGATCTTCAATGACCTCGTCGAGGCCGTCGGGCACACGCCCGTCGTGCGGCTGCGGACGGCACGCTCGGACGTGACCGTCGCGGCCAAGCTCGAACTGCAGAACCTGTTCGCGATGAAGGACCGGGTCGCCCGCCAGGTAGTTCTCGAAGCGCGCGCGAACGGGGTTCTGGCCCCCGGCGCGCCGATCATCGAGAGCTCCTCGGGCACCATGGCCCTGGGGCTCGCCCTGGCGGGCCACGCCCTCGGCCATCCGGTGCACATCGTGACGGACCCCCGGATCGACGCGATCACGCGGGCGAAGCTGACCGCGCTCGGCTGCTCGGTGCACGTGGTCGAGGCGATGACCGCGAACGGCTGGCAGAGCGCCCGGCTGGAGCGGCTGGCCGAGCTGCGCGCCGAGTACCCGGGGGCGTTCTGGCCCCGGCAGTACTCCAATCCGCAGAACCCCCTGGCGTACGCCGCCCTCGCCGACGAACTGGTGGCGGACCTGGGCCGGATCGACGTGCTCGTCGGCGCGGTCGGCAGCGGCGGATCGCTGTGCGGAACCGCCCGCGCGCTGCGCCACGCTCTGCAGGCCGCGGGAAGCTCCGGTCCGCTGCGGGTGATCGGCGTCGACGCCGTCGGCAGCGTCCTGTTCGGCCAGCCCGACCAGCCGGGACGTCGGCAGAGCGGCATCGGCAACAGCCTGATCCCGGCCAACCTGGACTACGCGGAGATCGACGAGATCCACTGGCTGAACGACCGGGAGGCCTTCGTCGCGACCCGCGAACTGGCCCAGGAGGAAGGGCTGTTCGCCGGAAATTCCTCGGGGTCGGTCTACCGGGTGCTGAGACACCTGGCCGACACCGTCGCCCCCGGCACACGTGTCGTCGGCATCTTCCCCGACCGGGGGGATCGCTATGTGGATTCGATCTACGACGACGCCTACTGGAAACGTGCCGGACTCGCCGGCCTCCCGCTGCGGATGGCACCGGCCACGGTGCGCTACGGCACCGAGGTGGACGGCTGGGCCCGGGCCGAGGTGCCGTCAACGCCCCGGCGGCGCCTGGTCTTCGTCGAGTCGAACACGACGGGCACCGGCATGCTGGCGCTCGCGCGCGCCAGGGACCTCGGGCTGGCACCCGTACTGCTCACCGGCCGGCCCGGCCGCTACCCCGGCATCGGCGAGGCCGACTGCCAGGTCATCCGCTGCGACACCAACGACGGGGACGCCCTGGCGGCGGCCCTGCGTACCCACTTCGCCCCCGGCGAGGTGGCTGGGGTGACGACCACCAGCGAGTTCTATCTGGAGGCCGTCGCCCGGCTGGCCGCCTCGCTCGGCCTGCCCGGCAACCCGCCCGCGGCCGTCGCCGCGTGCCGCCGCAAGTCGGCGACCCGCCGGCTGCTGACGGACGCGGGACTGCCACAGCCGGTCTCGGTGCCGGTGACGCGGGTGGCGGACATGCCCGACGCGGTCGCGGCCACCGGGCTGCCTTGCGTCGTCAAGCCGGCCTCGGACTCGGCGTCGACGGGCGTGCTGCTGTGCACCTCCGTCGAGCAGGCCCGCGACCACGCCGCGAAGCTGCTGGCGATCACGCACAACGTGCGCGACCAGGCGGTCCCGCCGGAGGTGCTCGTCGAGGAGCACGTCCAGGGTCCGGAGTACAGCGTGGAGACGATCTTCGTGGCGGGTGAGTTGCACGTCGTGGGCATCACCCGGAAGTCGGTGTCGCCCCCGCCCTCGTTCGTCGAACTCCGGCACACCTTTCCGGCACCGCTGGACACGGCCGGCTCGCGCGCGATCGAGCGGATGGTGCGGGCGGCGATCGAGGCGGTCGGGCTGCGGCACGGCGCCTGCCACACCGAGGTGCGCCTGACCGCGAAGGGGCCGACGATCATCGAGATCAACGCCCGGCTCGCAGGCGGCATGATTCCCGAGCTGATCAGGCTGGCCGGCGGGCCCGACCTGCTGACCCAGCAACTGCGCGCGGCGGCCGAGCTGCCCGTCGAACTGCCGCGGACGGAGCTGATCCCGACCGGCGTCGCCTTCCTCACCGGCTCCGCCGAGGGGCGGCTCGCGGGCCTGGAGGGCGTCGAGCCCGCCCGGCGACTGCCGGGGGTGGCCGAGGTCCTCGTCACGCGCCGCGCCGGCGACCCGATCCGTCCGGCCACCGACGCCTACGACCGGATCGGTCACGTCATCGCGTCGGCCGACTCGGTGGCGGAGCTCGACCGGACGCTGGACGCGGCGCTGGAGCACATCACTGTCCGATTGACGAACGACTGA	MIFNDLVEAVGHTPVVRLRTARSDVTVAAKLELQNLFAMKDRVARQVVLEARANGVLAPGAPIIESSSGTMALGLALAGHALGHPVHIVTDPRIDAITRAKLTALGCSVHVVEAMTANGWQSARLERLAELRAEYPGAFWPRQYSNPQNPLAYAALADELVADLGRIDVLVGAVGSGGSLCGTARALRHALQAAGSSGPLRVIGVDAVGSVLFGQPDQPGRRQSGIGNSLIPANLDYAEIDEIHWLNDREAFVATRELAQEEGLFAGNSSGSVYRVLRHLADTVAPGTRVVGIFPDRGDRYVDSIYDDAYWKRAGLAGLPLRMAPATVRYGTEVDGWARAEVPSTPRRRLVFVESNTTGTGMLALARARDLGLAPVLLTGRPGRYPGIGEADCQVIRCDTNDGDALAAALRTHFAPGEVAGVTTTSEFYLEAVARLAASLGLPGNPPAAVAACRRKSATRRLLTDAGLPQPVSVPVTRVADMPDAVAATGLPCVVKPASDSASTGVLLCTSVEQARDHAAKLLAITHNVRDQAVPPEVLVEEHVQGPEYSVETIFVAGELHVVGITRKSVSPPPSFVELRHTFPAPLDTAGSRAIERMVRAAIEAVGLRHGACHTEVRLTAKGPTIIEINARLAGGMIPELIRLAGGPDLLTQQLRAAAELPVELPRTELIPTGVAFLTGSAEGRLAGLEGVEPARRLPGVAEVLVTRRAGDPIRPATDAYDRIGHVIASADSVAELDRTLDAALEHITVRLTND	MQNKKIAVIFGGNSTEYEVSLQSASAVFENINTNKFDIIPIGITRSGEWYHYTGEKEKILNNTWFEDSKNLCPVVVSQNRSVKGFLEIASDKYRIIKVDLVFPVLHGKNGEDGTLQGIFELAGIPVVGCDTLSSALCMDKDRAHKLVSLAGISVPKSVTFKRFNEEAAMKEIEANLTYPLFIKPVRAGSSFGITKVIEKQELDAAIELAFEHDTEVIVEETINGFEVGCAVLGIDELIVGRVDEIELSSGFFDYTEKYTLKSSKIYMPARIDAEAEKRIQEAAVTIYKALGCSGFSRVDMFYTPSGEIVFNEVNTIPGFTSHSRYPNMMKGIGLSFSQMLDKLIGLYVE	216.33	gnl|BL_ORD_ID|1069|hsp_num:0	1157			342	678	vancomycin
BGC0000950.1|Napsamycin_16 # 18092 # 19135 # 1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.728	BGC0000950.1|Napsamycin_16 	18092	19135	+	Loose	700	31.187	CMY-26	28.77	3002037	protein homolog model	n/a	n/a	cephamycin	antibiotic inactivation	CMY beta-lactamase	ATGATCGAGATGCGAAGCGACACCTTCACCCTGCCCACCGAGGAGATGCTGTCGGCCATGGGCCGGGCGACCCTTGGGGACGACGTGTACGGCGAGGACCCCACCGTCAACCACCTGGAGGAACTCGCCGCGAAGAGCGTCGGCAAACCCGCCGCGTGCCTGATGCCCAGCGGCACGATGGCGAACCTCGCCGCCCTGCTCGTGCACGTGCCGCGCGGCGGCAAGGTGCTCGTCGGCGACGAGAGCGACATCTACCTGTACGAGGCCGGCGGGGCAAGTGTCTGCGGCGGCATGGTCTACGAGCCGATCCCCACCCGCCCCGACGGCACGCTCGCGCTGGACGACCTGGCCGCGGCCTTCCCGCCCGACCCGGACGACCCCCAGTTCGCGCTGCCGGGCCTCATCTGTGTGGAGAACACCCACAACCGGATGGGCGGCCGCGTGCTGGGCCAGGCGTACCTGGCCGAGCTCAAGGCCTTCGCCGCCGTGCACGGCGTCCCGGTGCACATGGACGGCGCCCGGATCTTCAACGCCGCCGTGGCGTCGGGGTTGCCGGCGGAGGAGATCGCCGCCCACGCGGACTCCGTCCAGTTCTGCCTCTCCAAGGGTCTGTCGGCGCCCATCGGCTCGATCCTCGCGGGATCGGCCGAGTTCATCGGGAAGGCGCGGCGCGTCCGCAAGATGCTCGGCGGCGGCATGCGGCAGGCCGGCGTGTTCGCGGCGGCCGGTACGGTCGCGCTGACCGACATGGTCGACCGGCTCGCCGAGGACCATCGGCTCGCGGCGCGGTTCGCGGCGGGCCTGGCGGAGGTGGACGGGATCGACGTCGCCCCGGGCTCCGTCACCACCAACATCGTCCTCTTCCGCGTCACGGCCGAGGGTCTGGACGCCGCCCGCTTCCTGGAAGACGCGCGGCAACGCGGCCTCGCCATGGGCGAGTTCGGGCACGGGCGGATCCGGGCAGTGACCCATCGGGGCCTCGGTCCGGCGGACGTCCCGGCCGCCGTGGCGATCGTGGCGGACGTGGTGCGCGCGGCGCGGTGA	MIEMRSDTFTLPTEEMLSAMGRATLGDDVYGEDPTVNHLEELAAKSVGKPAACLMPSGTMANLAALLVHVPRGGKVLVGDESDIYLYEAGGASVCGGMVYEPIPTRPDGTLALDDLAAAFPPDPDDPQFALPGLICVENTHNRMGGRVLGQAYLAELKAFAAVHGVPVHMDGARIFNAAVASGLPAEEIAAHADSVQFCLSKGLSAPIGSILAGSAEFIGKARRVRKMLGGGMRQAGVFAAAGTVALTDMVDRLAEDHRLAARFAAGLAEVDGIDVAPGSVTTNIVLFRVTAEGLDAARFLEDARQRGLAMGEFGHGRIRAVTHRGLGPADVPAAVAIVADVVRAAR	MMKKSLCCALLLTASFSTFASAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKTYYFTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWQDISLLHLATYTAGGLPLQIPDDVTDKTALLHFYQNWQPQWAPGAKRLYANSSIGLFGALAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKDYAWGYREGKPVHVSPGQLDAEAYGVKSNVTDMARWVQVNMDASRVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLANKSYPNPVRVEAAWRILEKLQ	91.08	gnl|BL_ORD_ID|1259|hsp_num:0	1373			654	870	
BGC0000950.1|Napsamycin_19 # 20727 # 22250 # -1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=GGC;rbs_spacer=7bp;gc_cont=0.676	BGC0000950.1|Napsamycin_19 	20727	22250	-	Loose	1000	199.134	almE	30.0	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGGCTCTCACGCTGGTCGAGCGATTTCTGCGCGGACTGGAGATTTCAGCCGACCGTTCCGCACTGCGGGTCGGTTCGGAGGACGTGACGTACCAGCAGGTGCACGACACGGCTCTGATATGGGCGGGTGCACTGCGGACCAACGGTTCTCCGGGCGCGGTCGGTGTGCTGACGGGGAAGAGCGTAACGACTTATGTGGGGCTTCTGGCGGTGCTGTACGCCGGTGGCACGGTCGTTCCGCTTCAGCCGAGTTTCCCTGCCGCGTTGACGCGGCGCATGATGAAGACGGCCGGCGTGAGGGAGGTCATCGCAGATGAGCGTGGCCTGGCGGTACTGCCGGAGGTCGTCAGGGATGGTATGACCGTCCGCGTCCTCGACAACGGCGGTTCCGTTACGGGATTCCCGCTGATTCCTGTATCCGCTGAATCGGCGCTTGCCGAACCGGTCGAGGTGGAACTCGCCGACCCGGCGTACATTCTCTTCACGTCAGGTTCGACAGGGATCCCCAAGGCCGTTCCCATCGCACACCGCGGTTTCGCGCACTATTTCGACGAGATGGACCGGCGGCTGGACTTCGGGCCGGACGATGTGCTGTCGCAGACCTTCGACCTCAATTTCGACCCCGGAATCCACGACGTCTTCGCCGCGTGGGGTGCGGGCGCGACGCTCCAGGCGGTGCCGCCGTCCGCGTACCGGGACCTCCCGGGGTTCGTCGCCGAGCACGGGATCACCGTCTGGCATTCCACGCCGAGCGGCATCTGGATGGCGCGGGAGATGGGTGCCCTGGAAAAAGGCGCCCTCGACGGTCTGCGGTGGTCCTTCTTCGGCGGGGAGGCCCTGCGCTGCCAGGACGTGCTGGACTGGCTGGTGGCGGCGCCCGGATCGAAGGTGGAGAACCTCTACGGGCCGACAGAGTTCTCGATCGGCGTGTGCTGGCACCGCTGGGCGGGCGAGGAGTCGCAGCGCCGCGGGGTGAACGGCACGGTCCCGATCGGCAAGGTCCACGCGGTCAACGACTTTCGCCTGGTGACCGAGGACGGCGAACAATCCTCGGTGGAAGGCGAGTTGTGGCTCACCGGACCGCAGATCTCGACCGGCTACCTCGATCCGGCCGAGAACGAAGGACGGTTCGTGGTCGCCGACGGACGGCGCTGGTACCGCACCGGTGACCGGGTCCGGGCACAACCGGATGGCGAGCTCGCCTACCTCGGGCGGATGGACTCGCAGGTGAAGATTCACGCCTGGCGGGTGGAGCTCGCGGAGGTGGACCACGTGGTGCGCGCCTGCGCCGGGGTGCTCGACGCGGTCACCGTCACCCGGTCGGCCGCGCACGGCGAGGAACTGGTGGTCTTCTACACCGGCGACGAGGTGCCTGATCAGGAGCTGGCCGACGGTGTGGGCGCCGTGCTCCCGGACACCGTCCTGCCGCGGCAGTACGTCCACCTGGAGAGCCTGCCGCTCAATCCCAACCGGAAGGTCGACCGCCTCGCCCTGAGGAAGCGGGCCGAGGAACTCGCCGGCTGA	MALTLVERFLRGLEISADRSALRVGSEDVTYQQVHDTALIWAGALRTNGSPGAVGVLTGKSVTTYVGLLAVLYAGGTVVPLQPSFPAALTRRMMKTAGVREVIADERGLAVLPEVVRDGMTVRVLDNGGSVTGFPLIPVSAESALAEPVEVELADPAYILFTSGSTGIPKAVPIAHRGFAHYFDEMDRRLDFGPDDVLSQTFDLNFDPGIHDVFAAWGAGATLQAVPPSAYRDLPGFVAEHGITVWHSTPSGIWMAREMGALEKGALDGLRWSFFGGEALRCQDVLDWLVAAPGSKVENLYGPTEFSIGVCWHRWAGEESQRRGVNGTVPIGKVHAVNDFRLVTEDGEQSSVEGELWLTGPQISTGYLDPAENEGRFVVADGRRWYRTGDRVRAQPDGELAYLGRMDSQVKIHAWRVELAEVDHVVRACAGVLDAVTVTRSAAHGEELVVFYTGDEVPDQELADGVGAVLPDTVLPRQYVHLESLPLNPNRKVDRLALRKRAEELAG	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	91.19	gnl|BL_ORD_ID|4935|hsp_num:0	5928			75	1638	colistin A; colistin B
BGC0000950.1|Napsamycin_20 # 22266 # 22397 # -1 # ID=1_20;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.591	BGC0000950.1|Napsamycin_20 	22266	22397	-	Loose	725	23.483	CepS	42.31	3003553	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	CepS beta-lactamase	GTGCGCGAGCGACCCGCGTATCTGGACAGTCTCCTGACGGATGTCAGTACAGGTCGGCACGTCCGGCGTCATGTACTGAATGAGTTAGGGGACGTGGTGTCGCGTTGGGCTTTTTTCCCGATCGGGAGTTAG	MRERPAYLDSLLTDVSTGRHVRRHVLNELGDVVSRWAFFPIGS	MKQTRALPLLALGTLLLAPLSLAAPVDPLKAVVDDAIRPVLKQHRIPGMAVAVLKGGQAHYFNYGLADVATGAKVNEQTLFEIGSVSKTYTATLGAYAVVKGGFKLDDQVSGHAPWLKGSAFDGITMAELATYSAGGLPLQFPDEVDSSDTMRAYYRHWTPPYQAGTQRQYSNPSIGLFGHLAASSLQQPFSTLMEQTLLPALGLEHTYLQVPEAAMARYAFGYSKEDKPIRVNPGMLADEAYGIKTGSADLLAFVKANISGVDDKALQQAIALTHTGFYRIGEMSQGLGWESYAYPVSEQTLLAGNSPAVSLKANPVTKFETPAAPGAMRLYNKTGSTGGFGAYVAFVPAKGIGIVMLANRNYPIEARVSAAHAILSQLAP	11.26	gnl|BL_ORD_ID|299|hsp_num:0	299			180	258	
BGC0000950.1|Napsamycin_22 # 22944 # 23765 # 1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.637	BGC0000950.1|Napsamycin_22 	22944	23765	+	Loose	500	27.335	OXA-36	23.22	3001430	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGGACAACCTTTTCGAGCGTGATGCAGAAGTGATTCTGACCTGGCGCGTCCAGGCCCGCCACCTGGGTGGATCCACTACCCAGGAAAGGATCAACCTGAAGGTCGGCGATCGGCTGGACTTCGGCATACCCAACGCCGGCGGAGAATTCCAGCCCCGTGCGACGCCCAGCATCGGCACTTTTGAGGTGTCCGACCAGCACCTCTTCTTCTCGAACTTCACCACCAGCACCACGTTCGTCATCGAGAATCTGGAGGGCGGGACCGAACTCGTCAAGGCGCGCCCCCGCCAGCTCGGCATGGTGATCCCGTTCGAGATGTCGCGCATCCTCATCCCCTCCAGCGCAAGCATCGGCGAACTCACCGTCTTCACATCCCCGCCCCGCCTGCTCGGGCCCGAGATGGCCGCCACGCCCACCGAGTCCGCGATGTCCAAACTGGACGCGACGACCAAGTACTTCGCCGTTCTCGTCGCCTTGTGCGAGCCGCGTCTGCGCGGTTCCTCGATGGCGGCTGTGCCCTCCGTCCAGGAGGTGGTGGAAAGACTGCGGGGGGTCGAGCAGTTCAGGGACGCCAACCGCAGCAGCGTCAACTACCACATCGACTATCTGGCTGACCAGAAGCTTCCGGTCAGCCAGTGGGCCAAGTACCTGAACGAAGGGCGCATGCATTCGAAGCGCGAGGCCCTGGTCGCCTTCTCGCTCCGCTTCGACCTGGTCCGCGAGGAACACCTCGCCCTCCTCCCCGACGTCAAACTCCTGCGCGCGCAACGATGTCTTGAGGCACGGCAAGCCACGAAGGTGGCAACGGGCGCGATCTCATGA	MDNLFERDAEVILTWRVQARHLGGSTTQERINLKVGDRLDFGIPNAGGEFQPRATPSIGTFEVSDQHLFFSNFTTSTTFVIENLEGGTELVKARPRQLGMVIPFEMSRILIPSSASIGELTVFTSPPRLLGPEMAATPTESAMSKLDATTKYFAVLVALCEPRLRGSSMAAVPSVQEVVERLRGVEQFRDANRSSVNYHIDYLADQKLPVSQWAKYLNEGRMHSKREALVAFSLRFDLVREEHLALLPDVKLLRAQRCLEARQATKVATGAIS	MFSLATFAHAQEGTLERSDWRKFFSEFQAKGTIVVADERQADRAMLVFDPVRSKKRYSPASTFKIPHTLFALDAGAVRDEFQIFRWDGVNRGFAGHNQDQDLRSAMRNSTVWVYELFAKEIGDDKARRYLKKIDYGNAYPSTSNGDYWIEGSLAISAQEQIAFLRKLYRNELPFRVEHQRLVKDLMIVEAGRNWILRAKTGWEGRMGWWVGWVEWPTGSVFFALNIDTPNRMDDLFKREAIVRAIL	110.98	gnl|BL_ORD_ID|843|hsp_num:0	916			36	600	cloxacillin; oxacillin; cefalotin
BGC0000950.1|Napsamycin_23 # 23760 # 24812 # -1 # ID=1_23;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.708	BGC0000950.1|Napsamycin_23 	23760	24812	-	Loose	325	25.0238	AAC(6')-31	34.48	3002585	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGGCCATGGGCTTCACCGCGGGCATCGCGGACTTCGACCAGAAGCAGTTCGACGCGCTCGACGTACGGGCCGGCGCGGCCTCCTCCTACGGTCGGCTCCGCCAGCACGAGGAGGACCGCCGGTGGGCCGCCCGCTACCTCGGATGGGTTGAGGGCGAGGTGCTGAGGGCGGTCGTGCCGGTGTACCGGCACCGCATGCGGTCGTGGGCCGACCCGTCGTACGACCCCCGCGCCTGGGGTCTTCCGGAGGGCGTGTCCGACGAGTTCACGCCGGCTACCTCGCTTCTGGTCGGCGGATGCCTCGACCGGCGCACCGGTTTCCACGTCGAGGCGGGAGCCAGGACGCCGGGCGAGCTGCGGAGGATTCTCGTCGAGCTTGCCCGGCTCGCCGCCGACGAGGACCGCGGCCTGGTGTTCCCCTACCTGTACGACGACGCCCGGGACGCGCTGGCGGCGGCGACGGAAGACCGCGTCGTGTGGGCCGAGCTCGGGCGGGAGGCCCATCTGTACGGGGTGGCCGATCCGACGTGGGAGCAGGTACTCCCGTCCAGGGTGCGCTACCGGCTCCGGCGGGACCGGCGCGTGATCGAGGACGTCCCCATGACGGTGGCTGAGGAGTCCTGGGACGATGTCGACGAGTGGGCTTCCCCGTTGATCGCCGACCACAACGCGGCCAAGGGGCAGCGGGAGCCGGCCGAGTTCGTGAGTTTTCGCTTCTCCCGCTGGCAGGAGAACCCGGACGTTCGGCTGCTGGCCTTCACGGCCGAGTCGGCCGGACTGCGGGGCGTTCAGTCGGTCCTGGTGTGGGGCGACGAGCTGGAATTGTACGAGATCGGGCTGGCCGGCGAGGAGAGTGACGAGCGCTTGGCGCTGTACCTCAACCTGCTCTTCCACCAGCCGATCCGGTACGCGCGAAGCCTCGGCATCGATCACATACGTCTCGGCTCGAAAGCGGAGACGGCGAAGGGACGGCGGGGCGGCGTCTTCGCCACCCTGCACGGCGGAGTTCTCGGCCGTGCCGAGACACGCGCCCTCGCGCGCGCCGGCTCATGA	MAMGFTAGIADFDQKQFDALDVRAGAASSYGRLRQHEEDRRWAARYLGWVEGEVLRAVVPVYRHRMRSWADPSYDPRAWGLPEGVSDEFTPATSLLVGGCLDRRTGFHVEAGARTPGELRRILVELARLAADEDRGLVFPYLYDDARDALAAATEDRVVWAELGREAHLYGVADPTWEQVLPSRVRYRLRRDRRVIEDVPMTVAEESWDDVDEWASPLIADHNAAKGQREPAEFVSFRFSRWQENPDVRLLAFTAESAGLRGVQSVLVWGDELELYEIGLAGEESDERLALYLNLLFHQPIRYARSLGIDHIRLGSKAETAKGRRGGVFATLHGGVLGRAETRALARAGS	MTEHDLPMLHDWLNRPHIVEWWGGEETRPTLAEVLEQYLPSALAKESVTPYIAMLDEEPIGYAQSYIALGSGDGWWEDETDPGVRGIDQSLANPSQLGKGLGTKLVCALVEMLFKDAEVTKIQTDPSPNNLRAIRCYEKAGFVAQRTINTPDGPAVYMVQTRQAFEQARSAV	203.49	gnl|BL_ORD_ID|1000|hsp_num:0	1093			96	258	neomycin; amikacin; sisomicin; netilmicin; kanamycin A; tobramycin; isepamicin; gentamicin
BGC0000950.1|Napsamycin_24 # 24865 # 26148 # -1 # ID=1_24;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.699	BGC0000950.1|Napsamycin_24 	24865	26148	-	Loose	770	67.781	tet(V)	24.29	3000181	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGACGGAAGTGGCGAACGATTCTCAGGGTGTCGAAACAGAAGTCGAACGCCCGAGTCTTTGGCGGCAGCGCGACTTCATGCTCCTGTGGAGTGGTCTGACGCTCAGCGAGGTGGGATCGGCGGTCACCCGGGTCGCCCTGCCGCTGGTCGCGGTCGTCGTCCTCGACGCGAGCACATTCCAGGTCGGGCTGCTCACGGCCGCCACCACCGCGGCGTTCGCGGTGTTCGCGCTGCCCGCCGGCGCGATCGTGGACCGGCACCGCAAGCGCTCCCTCATGATCGTCTGCGATCTGCTGCGCCTGCTGATCCTTGGCTCGGTACCGCTGGCCGCCGCCTTCGACGTGCTGACGATGGGGCAGCTCTACATGGTCGCGCTCGCGGCCGGTGTGTGCACCGTGTTCTTCGACGTCTCGTACCAGAGCTACCTGCCCTCGCTGATCCGCACCGACGAGCTGATGGCGGCCAACGGCAAGCTCGGCACCACTCAGTCGCTGGCGCAGCTCGGCGGGCCGAGTCTGGGCGGCGGGCTGGTCGCTCTGGTGGGCGCTGCCATGGCGATCGTCGTGGACGCGCTGTCCTACGCTCTCTCGATGCTGGCGATGCTCGGCATCCGGCGGAGGGAGGAGCCGCCGCCCCCGCCGCCCGCGGACGAGCCGCTGAGCCGCCGGATCACCGAGGGGCTGCGGTTCGTCTTCGGCCACCCGATCCTGCGCCGGGTGGTGATCTGCACGGGCACAGGGAACCTGTTCGGAGGCATGACCGCGGCGTTGGCCATGGTGTTCCTGGTCCGCGAGCTGCACGTCGGCCCGGCGCTGACCGGCCTGATCCTGGCGGTTTCGGCGATCGGCGGCATCCTCGGGGGGATGTTCGCGGGCAGGCTCGCCGAGCGGGTCGGCTCGGCCCGGATCATCTGGGTGTCCTTGCTGGTCTTCAGCGCGCCTCAGGTCATCGCGGCGGCTGCCTGGGAGGGCTGGGGCGCACTGCTCTTCCCGCTGGGCTGGGCTTGCGCCGGTTTCGCGTACATGGTCTACAACATCGCCCAGGTGACCTACCGGCAGTCGGTGACTCCACCGGAGTTGATGGGCCGGATGAACGCCGCCGTCCGCTGGGTGGTGTGGGGCACCATGCCGATCGGCAGCCTGCTCGGCGGAGCGCTCGGCAGCCTGATCGGAGTGCGCCCCGCCCTCGTGGTGGCCTTCGCGGGTTCCTGGGCGGCCGGCTGGTTCGTGTTCTTCTCACCGCTCCGCCGCATGCGGGACATCCCCCGACCCGAAGCGGGTTGA	MTEVANDSQGVETEVERPSLWRQRDFMLLWSGLTLSEVGSAVTRVALPLVAVVVLDASTFQVGLLTAATTAAFAVFALPAGAIVDRHRKRSLMIVCDLLRLLILGSVPLAAAFDVLTMGQLYMVALAAGVCTVFFDVSYQSYLPSLIRTDELMAANGKLGTTQSLAQLGGPSLGGGLVALVGAAMAIVVDALSYALSMLAMLGIRRREEPPPPPPADEPLSRRITEGLRFVFGHPILRRVVICTGTGNLFGGMTAALAMVFLVRELHVGPALTGLILAVSAIGGILGGMFAGRLAERVGSARIIWVSLLVFSAPQVIAAAAWEGWGALLFPLGWACAGFAYMVYNIAQVTYRQSVTPPELMGRMNAAVRWVVWGTMPIGSLLGGALGSLIGVRPALVVAFAGSWAAGWFVFFSPLRRMRDIPRPEAG	MRSPRPVAGWRVLAPFRIREYRLLIAAVTLSIFAEGMWSVVMALQVIAIDNDPASLSLVATCLGVGLVAFVLVGGITADRINQRTIIIAVEVVNFVTVAVISALALLGVLKIWHMAVAAGILGIAAAFFFPAYSAILPRILPPEQLLAANGVEGVVRPVFQRSVGPAVAGMVIGATMPSIGAVVVAVLFALGLALLVATRPPAQPASEHHERPHVLRDLREGFAFVLKTPWLLWTVLFASMFVLVVLGPIEVLLPFIAQDRFADGARAYGFILAFFGIGSAMGALTVSSRRMPRRYLTTMMLMWGLGSIPLVIVGYTSSFPLMAAATFVIGVTDGAGMVIWGTLLQRRVPTEMLGRVSSLDFFVSLAFMPLSFAIVGPLSKVVSMEVIFATAGLVPVAIAAVAFTAARMHRDEVANPLL	101.91	gnl|BL_ORD_ID|1041|hsp_num:0	1006			45	1158	tetracycline
BGC0000950.1|Napsamycin_29 # 30800 # 31138 # 1 # ID=1_29;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.676	BGC0000950.1|Napsamycin_29 	30800	31138	+	Loose	570	25.0238	AAC(3)-IId	37.84	3004623	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	ATGAGTCCCCCCCTCTGCCTCGTGCACTTCCTGCCGATGCGTCCGAAGCGATGGGGGAGCTCGGCCGGGCGCCCGCTGCTGAATCAGTTCGGCTGCTCGAAGACGCCGCGCAGAGAAGGCACCTTTCCGGACACGAGCTTGCGCTGGCCCGTGCGGCGCGAGAGGAGATCAAGCGACGCGCATCCCGCGTTTCCGCGTTGGTCGGGAGGGTGGAGGGCATCTCGCTCACTGCAGACGAGTGTTCCCTTCTACGACCGCCCTTCGGCCGCGCCACCCATCTGCCCAGTCCCGATCGTCCGTATGTGCATCTGGCCGTTCACACGGGACGGGGCGGCGTGA	MSPPLCLVHFLPMRPKRWGSSAGRPLLNQFGCSKTPRREGTFPDTSLRWPVRRERRSSDAHPAFPRWSGGWRASRSLQTSVPFYDRPSAAPPICPVPIVRMCIWPFTRDGAA	MHTRKAITEALQKLGVQTGDLLMVHASLKAIGPVEGGAETVVAALRSAVGPTGTVMGYASWDRSPYEETLNGARLDDEARRTWLPFDPATAGTYRGFGLLNQFLVQAPGARRSAHPDASMVAVGPLAETLTEPHELGHALGEGSPVERFVRLGGKALLLGAPLNSVTALHYAEAVADIPNKRWVTYEMPMLGRDGEVAWKTASDYDSNGILDCFAIEGKPDAVETIANAYVKLGRHREGVVGFAQCYLFDAQDIVTFGVTYLEKHFGTTPIVPPHEAVERSCEPSG	39.16	gnl|BL_ORD_ID|2106|hsp_num:0	3322			249	360	dibekacin; sisomicin; netilmicin; tobramycin; 6'-N-ethylnetilmicin; 2'-N-ethylnetilmicin; gentamicin
BGC0000950.1|Napsamycin_31 # 32220 # 33800 # -1 # ID=1_31;partial=00;start_type=ATG;rbs_motif=GGC;rbs_spacer=5bp;gc_cont=0.712	BGC0000950.1|Napsamycin_31 	32220	33800	-	Loose	1000	151.369	almE	26.04	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGCGCGCTGCCATGACCGCCGCAGAGCAGCGGTCTCTGCTCGACACGGCCGTTTCCCTGCCCGATCTCTTCCGCGCTGTTGCTGCGGCCCGTGGTGCCGCCCCGGCCCTCCGAGACGGCGAGCGGACCCTCAGCTACCGCGAGCTCGACGACCTGACGGACCGGATCGCCGCACGCCTGGCGGCGGAAGGGGTCCGACCGGGCGACCGGGTGGGGATCCTCCTCCCACGCTCGGCCGAGACGCAGATCTCCATCCTGGCCGTCCTCAAGGCCGGAGCCGCCTATGTCCCGCTCGACCCCTCCTATCCGGCGGAGCGGTTGCGCTTCCTGGTACGCGACGCTGACATCGGGGTGGTCGTCGGCGACGCCGGGCACTGCGCTGCCGGCGGGCTCAAGGATGTCCGTGTCCTCGCCCCCGAGGCCGAGGAGACGATCCCGCCGGCGCCGCCCGTCCCCCTCGACGGCAGCGAATTGGCGTACGTGATCTACACCTCCGGCTCGACCGGCACGCCCAAGGGGTGCATGGTCCAGCACACCAGCGTCCTCGACCTGGTCCGCGGCGTGATGTCGGTGGTCGACCTGGACACGGAGGACCGCGTCGGGCTCTTCCTCCCGTTCATCTTCGACGGGTCCGTCCTCCAGTTCTGGCTCTCCCTGGCGGCCGGCGCGACGGCCGTCGTCGTCCCGGCCCGGGTGGCGCAGTCGATGCCCGACTTCCTCGACCTGCTTCGACGCGAGGCCGTGACCCTCGTCATACAGGTCCCCACGACGCTGCGGGCGCTCGCCCACGCCCACGAGGCGGCGGGCCGGCCTCCCCTCGCCCTCCGGTACGTCCTGGTGGGCGGCGAGAGCGTGGAGCTTGATGTCGTCTCCGCCTTCCTCGCGCGCTGCCCGGGCACGCCGCCCGAGGTCGTCAACATCTACGGACCGACCGAGGCGGCCTGCGTCGCCACCTGTCGCGTGCTGACCCAGGAAGACTTCGACGGCCCCGTGCCCTCACCGATCGGTACGGCGCTGCCGCACCTGCTCGTCGAGGTACGCGGCGAGGCCATGGAGCCGGTCCCGGACGGAGAGGTCGGCGAACTGGTGATAGCCGGCTCGGGCGTGGCCGTGGGCTACCTGGGGCGCCCCGAACTGACAGCCGAACGCTTCGTCGTCCTCGACACTCCGCAGGGGCCGGTGCGCTACTACCGGACCGGGGACCTGGCCAGACGGCTGCCGGACGGCGCCTTCGCGTACCTGGGCCGCAACGACCAGCAGGTCAAGGTGCGTGGCATCCGTGTGGAACTCGGCGAGGTGGAGACGTATCTGCGTGCCCACCCGATGGTCAGGGAAGCCGCCGCCACGGTGGTCGACACCCAGGCCGGCGCCCAGTTCCTGACCGCGTGTGTGGTGCTCGCCGACCAAGCACCGGAAAAGCCCGAGGCGTTGCTGCGGCAGCACATGCTCGCTTCCCTTCCGCCCTTCATGGCGCCGGATCGCTATCAGTTCGTCCCTGAGCTGCCGTCGACGGACTCAGGCAAGCTGGACCGCCGCGCTGTGCACGACATGGCAACTCCGCGTCGAGCTCCCCGCCCCTGA	MRAAMTAAEQRSLLDTAVSLPDLFRAVAAARGAAPALRDGERTLSYRELDDLTDRIAARLAAEGVRPGDRVGILLPRSAETQISILAVLKAGAAYVPLDPSYPAERLRFLVRDADIGVVVGDAGHCAAGGLKDVRVLAPEAEETIPPAPPVPLDGSELAYVIYTSGSTGTPKGCMVQHTSVLDLVRGVMSVVDLDTEDRVGLFLPFIFDGSVLQFWLSLAAGATAVVVPARVAQSMPDFLDLLRREAVTLVIQVPTTLRALAHAHEAAGRPPLALRYVLVGGESVELDVVSAFLARCPGTPPEVVNIYGPTEAACVATCRVLTQEDFDGPVPSPIGTALPHLLVEVRGEAMEPVPDGEVGELVIAGSGVAVGYLGRPELTAERFVVLDTPQGPVRYYRTGDLARRLPDGAFAYLGRNDQQVKVRGIRVELGEVETYLRAHPMVREAAATVVDTQAGAQFLTACVVLADQAPEKPEALLRQHMLASLPPFMAPDRYQFVPELPSTDSGKLDRRAVHDMATPRRAPRP	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	94.60	gnl|BL_ORD_ID|4935|hsp_num:0	5928			114	1629	colistin A; colistin B
BGC0000950.1|Napsamycin_32 # 33811 # 34581 # -1 # ID=1_32;partial=00;start_type=ATG;rbs_motif=GGC;rbs_spacer=6bp;gc_cont=0.678	BGC0000950.1|Napsamycin_32 	33811	34581	-	Loose	550	42.743	Erm(49)	25.32	3004626	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGTCGGACCAGGATCGTCGGGCACGGTTGATCCGTGCCCTGGAGTACCGGCAGATCTTCGACGACCGGCTCGACCGGATCGAGCGGCAGGTTCCGTTCGACTCGGTCCACGATGTCGACACCTCGGAATCCGTGGAGCTGTGGGAACTCCCCCAGGGCGACCAGCTCCAGGTGGGACGGGACGCGCGGTACTCACCCACACCGGTCCGCACGGTGCGCCACGTGCTCGGCCAGTGCGACGTGAAACACGAGGACATGACGTTCGTCGACGTCGGCTGCGGCAAGGGGCGGGTCCTTCTGCAGGCCACCGAGTTCCCTTTCCGGCGCATTGTCGGTGTCGAGGCGTCAGAGACGCTCTGCGACATCGCCCGGGCCAACGTCGAGAAGGCGTCGGCGACACTCGAGGGCTGCGACCGGATCGATGTGGTGCACGCAGACGCCACCCGGTTCGACGTCCCGGACGACGCCGGGCTCTTCTACTTCTACGAGCCGTTCTCCACGGAAGTGTCCTCGGCCGTACTGGAGAGGATCGAGGATTCCGTGCGCCGTCACCCGCGTCCCGTCGTCCTCTGCTTCACCGGCCGGGGCCAGCCCGACGGCCAGGCCGGCGAGCACGACACCCCTCCAGTTGCCGCCGCCGCCGCGGAGATTCGACCCCGATGGAAGCGGATCGGCACCGTCAGCTCCCCGGACGCCGTGTTCTACGACTCCCTGCTGTACGCGTACGAGGACCACGGCTCGTTCGAGGCCCAGGCCGTCCCGGATTCCTGA	MSDQDRRARLIRALEYRQIFDDRLDRIERQVPFDSVHDVDTSESVELWELPQGDQLQVGRDARYSPTPVRTVRHVLGQCDVKHEDMTFVDVGCGKGRVLLQATEFPFRRIVGVEASETLCDIARANVEKASATLEGCDRIDVVHADATRFDVPDDAGLFYFYEPFSTEVSSAVLERIEDSVRRHPRPVVLCFTGRGQPDGQAGEHDTPPVAAAAAEIRPRWKRIGTVSSPDAVFYDSLLYAYEDHGSFEAQAVPDS	MRNIKDTQNFLHSKELVRHLIGICNIKLDDVVIEIGPGKGIITNELAHKARKVVAIEFDEELYEKLKNKFQSNNKVDIIYGDILNYTPRIPSYCVFSNIPFNITSEILNKFLSDKKNEKMFLIMQYEPFIKYAGNPYGAETLRSMLYKPFFDMDLKYRFDPSDFKPAPQARIVLASFERKQFPDVKKEEEKLYKDFLAYIYTNKGETFFAKIKTLFSSNQIKRVWGQIKIDKTTKISEVPYESILKVFKLFFLYGTDANKQLVVNSFNNMNKQNNKLQKNHRNNSKAKSWNSNRKRKPYHRNNV	84.21	gnl|BL_ORD_ID|2108|hsp_num:0	3324			48	258	erythromycin; clindamycin
BGC0000950.1|Napsamycin_1 # 1 # 1035 # -1 # ID=1_1;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.713	BGC0000950.1|Napsamycin_1 	1	1035	-	Loose	375	26.1794	nalD	32.61	3000819	protein overexpression model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; peptide antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; sulfonamide antibiotic; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCTCCGCATCCACTTCAATGACGCGGATCTGGCCAGGACCCGGCTCGCCCCCGCTCCCGACCCGCTGTTCGAGGTGGCCGCGAGCATGCACCGGCTGCAGTCCGGCCGAGGTCGCTGGGCCTACGCCGGGTGGTATCGGGAGGCGCGGCGGGATCTTCGGGAGCAGGGGTTGGAGCGGGCGTTGCGGAGTGTTCTGTTGCCGCTGTATCCGAGGGCCGCTTATTACCCGGACTTTCTGACGCCGTCCTCCGGGGTGGAGGGGCTGGAAGCGGGGCTGGAGGCGTTGCTGGCCACGCCGGCGGAGCGGGTCGCGGAGGAGGTCGGGATGCTGGACCGGCTCATCGGGGCGCCGGGGTGGGCGGGGCGGTTGGGCGAGCAGGAGGTGCGTCGGGAGTTCGTGGGGGTGCTGCGGGCGTATCACGATGCGGTCGTCGTGCCGCATCAGGATCGGATCCAGGCGCGGATCGAGGCTGAGCGGGCGGCACGGGGGCGGGGGCTGCTGCATGGCGGGGTCGAGGGCATGCTCGCGGGGCTCGGTTCCATGTTCCGGTGGTGTCCGCCGGTGCTGGAGGTCGCGTATCCGCGGCAGACGCAGGACCGGGATCTGTATCTGAACGGGCGTGGGCTCACCCTTGTTCCCTCGTATTTCAACTGGGGTGAGCCGGTCGCGTTCGCCGATCCCGGGTTGCCGCCGGTGCTCTGGTACTCGCTGTTGCACGAGCCTGCGGCCCGCCCCTTGCGGGAAGAGGATCCTGAGCGGTCTCTGGTCAATCTGCTCGGGCGGGCCCGGGCGGTCGCTCTGCGGGCGGCGGCCGGTGGTGCCACGACGGGGGAGATCGCCCGGGCGGCCGGGGTTTCGGCGTCCGCCGCCAGTCGGCATGCCACGGTGCTGCGTGATGCGGGGCTCATCACGACTGCCCGTCATGGGGCGGCTGTTCTGCATACGCTCACCCCTGCCGGTGCGTCTGTTCTGCGTGCGGCCCGGAGTGCGGCGGGCGAGGCGGCTGTGGACGGTCGCGTCGAGCTGAGCTGA	MLRIHFNDADLARTRLAPAPDPLFEVAASMHRLQSGRGRWAYAGWYREARRDLREQGLERALRSVLLPLYPRAAYYPDFLTPSSGVEGLEAGLEALLATPAERVAEEVGMLDRLIGAPGWAGRLGEQEVRREFVGVLRAYHDAVVVPHQDRIQARIEAERAARGRGLLHGGVEGMLAGLGSMFRWCPPVLEVAYPRQTQDRDLYLNGRGLTLVPSYFNWGEPVAFADPGLPPVLWYSLLHEPAARPLREEDPERSLVNLLGRARAVALRAAAGGATTGEIARAAGVSASAASRHATVLRDAGLITTARHGAAVLHTLTPAGASVLRAARSAAGEAAVDGRVELS	MRRTKEDSEKTRTAILLAAEELFLEKGVSHTSLEQIARAAGVTRGAVYWHFQNKAHLFNEMLNQVRLPPEQLTERLSGCDGSDPLRSLYDLCLEAVQSLLTQEKKRRILTILMQRCEFTEELREAQERNNAFVQMFIELCEQLFARDECRVRLHPGMTPRIASRALHALILGLFNDWLRDPRLFDPDTDAEHLLEPMFRGLVRDWGQASSAP	162.26	gnl|BL_ORD_ID|2335|hsp_num:0	1213			12	150	erythromycin; ciprofloxacin; tetracycline; ceftazidime; ceftriaxone; meropenem; novobiocin; azithromycin; trimethoprim; sulfamethoxazole; chloramphenicol; aztreonam; colistin A; colistin B; ampicillin; nalidixic acid; panipenem; ticarcillin; trimethoprim-sulfamethoxazole
